About Us

HOME>About Us

Vision and Mission

Having proprietary platforms and unparalleled technologies for the development of antibody drugs, as well as comprehensive patent deployment, AM continues to deepen core capabilities for the R&D of antibody drugs that will treat human diseases. We aim to become the best antibody drugs developer based in Taiwan, while pursuing global strategic alliances and promoting an authentic made-in-Taiwan international brand.

With rapid biotechnology advances, drugs for cancer treatment have improved dramatically, evolving from small-molecule drugs to protein-based drugs, including antibody-drug conjugates (ADC) and CAR-T therapy.

AM is committed to the development of potential antibody drugs, boosting our competitiveness, improving human health and wellbeing, and promoting the antibody derived biological drugs through global collaboration.